DI STEFANO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 3.801
EU - Europa 2.117
AS - Asia 1.917
SA - Sud America 219
AF - Africa 49
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.118
Nazione #
US - Stati Uniti d'America 3.750
SG - Singapore 762
RU - Federazione Russa 594
CN - Cina 497
IT - Italia 305
FI - Finlandia 282
UA - Ucraina 244
HK - Hong Kong 221
BR - Brasile 179
DE - Germania 163
VN - Vietnam 146
IE - Irlanda 114
PL - Polonia 94
GB - Regno Unito 90
FR - Francia 85
JP - Giappone 76
SE - Svezia 56
IN - India 45
CA - Canada 22
KR - Corea 21
IQ - Iraq 20
NL - Olanda 17
BD - Bangladesh 16
MX - Messico 16
RO - Romania 16
TR - Turchia 16
AR - Argentina 13
BE - Belgio 13
AU - Australia 12
UZ - Uzbekistan 12
AT - Austria 10
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
SA - Arabia Saudita 10
PK - Pakistan 9
CO - Colombia 7
KE - Kenya 7
MA - Marocco 7
PH - Filippine 7
VE - Venezuela 7
JO - Giordania 6
NP - Nepal 6
ZA - Sudafrica 6
EC - Ecuador 5
EG - Egitto 5
ES - Italia 5
ID - Indonesia 5
IR - Iran 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
DZ - Algeria 4
JM - Giamaica 4
LB - Libano 4
PS - Palestinian Territory 4
BY - Bielorussia 3
CL - Cile 3
DO - Repubblica Dominicana 3
OM - Oman 3
PY - Paraguay 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MC - Monaco 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.118
Città #
Singapore 550
Fairfield 470
Ashburn 445
Woodbridge 266
Chandler 227
Hong Kong 211
Houston 190
San Jose 180
Wilmington 173
Seattle 162
Cambridge 150
Ann Arbor 149
Jacksonville 132
Dublin 114
Moscow 88
Zgierz 84
Des Moines 78
Medford 77
Tokyo 75
Beijing 74
Frankfurt am Main 68
Nanjing 67
Los Angeles 61
Palermo 57
Santa Clara 55
Ho Chi Minh City 50
Princeton 46
Altamura 41
Lauterbourg 39
New York 37
Boardman 36
Hanoi 34
San Diego 34
Lawrence 33
Tulsa 32
Helsinki 28
Dallas 24
Shenyang 24
Hefei 22
Buffalo 21
Milan 20
Council Bluffs 19
Jinan 16
Nanchang 16
The Dalles 16
Dearborn 15
Changsha 14
Chicago 14
Jiaxing 14
London 12
Seongnam 12
Tianjin 12
Zhengzhou 12
Brussels 11
Hebei 11
Izmir 11
Kumar 11
Abidjan 9
Amsterdam 9
Baghdad 9
Orem 9
São Paulo 9
Tashkent 9
Guangzhou 8
Haiphong 8
Rio de Janeiro 8
Saint Petersburg 8
Columbus 7
Ludwigshafen am Rhein 7
Atlanta 6
Bexley 6
Biên Hòa 6
Brno 6
Central District 6
Chennai 6
City of London 6
Curitiba 6
Durham 6
Hangzhou 6
Kunming 6
Lake Forest 6
Montreal 6
Nairobi 6
Nuremberg 6
San Mateo 6
San Paolo di Civitate 6
Amman 5
Auburn Hills 5
Denver 5
Fuzhou 5
Lanzhou 5
Munich 5
Newark 5
Norwalk 5
Ottawa 5
Philadelphia 5
Phoenix 5
Porto Alegre 5
Rome 5
Verona 5
Totale 5.212
Nome #
Hepatitis B virus reactivation and alemtuzumab therapy 310
HCV genotypes in Sicily: is there any evidence of a shift? 310
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin 287
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 278
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay 263
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 242
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 239
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 237
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 226
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. 224
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model 215
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 214
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 211
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome 204
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial 204
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission 202
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 199
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study 195
Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity 194
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction 188
Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico 179
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. 174
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier 172
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir 172
Modulation of epitope-specific anti-hepatitis C virus E2(anti-HCV/E2)antibodies by anti-viral treatment 171
HCV genotypes in western Sicily: any evidence for a shift? 169
Sustained response after lamivudine treatment in HBe minus chronic hepatitis B 167
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? 167
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS 162
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) 162
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano 160
Infezione occulta da HBV in pazienti con malattie oncoematologiche 157
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale 156
Flaviviridae 136
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 131
Hepatitis C virus clearance and gender 130
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV 126
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 123
Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale 121
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? 119
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin 112
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 109
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients 107
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 107
Rhabdoviridae 104
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 72
Totale 8.307
Categoria #
all - tutte 26.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 0 50 67
2021/2022497 25 128 0 16 13 17 22 16 68 64 28 100
2022/2023651 71 131 9 58 79 103 51 38 61 2 28 20
2023/2024239 21 35 16 30 29 42 14 14 6 12 0 20
2024/2025817 14 50 41 86 28 36 49 59 68 88 105 193
2025/20262.880 187 78 124 178 245 478 426 329 229 513 93 0
Totale 8.307